NCT05470218View on ClinicalTrials.gov

Leucine, MTOR and Athero

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

August 14, 2023

Study Completion Date

August 14, 2026

Conditions
Atherosclerosis
Interventions
OTHER

Meal

Liquid mixed meal with different amounts of protein and leucine

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

University of Missouri-Columbia

OTHER